On April 22, 2024, Zydus Lifesciences Ltd informed in an exchange filing that the company launched Mirabegron Extended-Release tablets in the United States of America. Details of the New Launch Zydus Lifesciences Limited announces the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States market. The company had earlier received final approval from …